RGWCX
Price
$22.26
Change
+$0.20 (+0.91%)
Updated
Jun 2 closing price
Net Assets
333.4M
VIGRX
Price
$214.29
Change
+$1.43 (+0.67%)
Updated
Jun 2 closing price
Net Assets
269.26B
Interact to see
Advertisement

RGWCX vs VIGRX

Header iconRGWCX vs VIGRX Comparison
Open Charts RGWCX vs VIGRXBanner chart's image
Victory RS Growth C
Price$22.26
Change+$0.20 (+0.91%)
VolumeN/A
Net Assets333.4M
Vanguard Growth Index Investor
Price$214.29
Change+$1.43 (+0.67%)
VolumeN/A
Net Assets269.26B
RGWCX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGWCX vs. VIGRX commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGWCX is a Buy and VIGRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 269B vs. RGWCX (333M). VIGRX pays higher dividends than RGWCX: VIGRX (0.35) vs RGWCX (0.00). RGWCX was incepted earlier than VIGRX: RGWCX (18 years) vs VIGRX (33 years). RGWCX (3.52) is less costly to investors than VIGRX (0.17). RGWCX is a more actively managed with annual turnover of: 50.00 vs. VIGRX (11.00). RGWCX has a lower initial minimum investment than VIGRX: RGWCX (2500) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 17.83 vs. RGWCX (4.45). VIGRX return over 5 years is better than : 109.40 vs. RGWCX (34.59).
RGWCXVIGRXRGWCX / VIGRX
Total Expense Ratio1.930.171,135%
Annual Report Gross Expense Ratio3.520.172,071%
Fund Existence18 years33 years-
Gain YTD-0.5860.743-79%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets333M269B0%
Annual Yield % from dividends0.000.35-
Returns for 1 year4.4517.8325%
Returns for 3 years45.8070.0665%
Returns for 5 years34.59109.4032%
Returns for 10 years29.38281.4210%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMCB1.070.04
+4.35%
PharmaCyte Biotech
IKT2.050.04
+1.99%
Inhibikase Therapeutics
AC37.780.46
+1.23%
Associated Capital Group
GBDC15.14-0.07
-0.46%
Golub Capital BDC
CAG22.76-0.13
-0.57%
Conagra Brands